Results 21 to 30 of about 62,039 (256)
Proton Pump Inhibitors and Clopidogrel [PDF]
Cardiovascular Therapeutics, 2010 Proton pump inhibitors are often prescribed for patients on clopidogrel to prevent gastrointestinal bleeding complications. Recent data suggest higher rates of adverse cardiovascular events in patients on proton pump inhibitors and clopidogrel, in comparison to patients on clopidogrel only.
Michael A, Gaglia, Ron, Waksman
openaire +2 more sources
PLoS ONE, 2019 Stroke patients are at high risk of developing pneumonia, which is major cause of post-stroke mortality. Proton pump inhibitors and H2 receptor antagonists are anti-ulcer drugs, which may predispose to the development of pneumonia by suppression of the ...
Tae-Jin Song, Jinkwon Kim
doaj +1 more source
The impact of drug-drug interactions between proton pump inhibitors and metformin: A systematic review of clinical evidence [PDF]
PharmaciaMetformin, a substrate of the organic cation transporters, is commonly co-prescribed with proton pump inhibitors, which inhibits these transporters. However, the clinical significance of this potential drug-drug interaction remains unclear.
Ria Andani Antong +3 more
doaj +3 more sources
Iron deficiency anemia from iron malabsorption caused by proton pump inhibitors
eJHaem, 2020 Background Iron deficiency anemia without evidence for blood loss can present a diagnostic challenge. Proton pump inhibitors have been associated with iron deficiency anemia for many years, yet the relationship between the two until recently was not ...
Michael Boxer
doaj +1 more source
Anaphylaxis to proton pump inhibitors
Allergologia et Immunopathologia, 2002 Proton pump inhibitors (PPI) are widely used for the treatment of peptic ulcer, but cases of anaphylactic reactions have rarely been described. We present a patient who experienced an episode of urticaria 30 minutes after oral intake of an omeprazole capsule. Skin prick tests to omeprazole, pantoprazole and lansoprazole were positive.
P, González +3 more
openaire +2 more sources
Лечащий Врач, 2021 Proton pump inhibitors are a diverse class of drugs with unique acid suppression properties. The aim of the work was to present the therapeutic benefits of rabeprazole and pantoprazole in clinical practice.
E. A. Lyalukova +3 more
doaj +1 more source
Dermatology Practical & Conceptual, 2015 Background: Sweet’s syndrome, also referred to as acute febrile neutrophilic dermatosis, can either occur as an idiopathic disorder or associated with another condition, including cancer, or induced by exposure to a drug.
Philip R. Cohen
doaj +1 more source
Proton pump inhibitors overuse - consequences among patients
Journal of Education, Health and Sport, 2019 Introduction Omeprazole was first proton pump inhibitor (PPI) approved for use by patients. Thirty years have passed since then. Due to their effectiveness, low price and safety proton pump inhibitors have become one of the most frequently prescribed ...
Patrycja Kmiotek +2 more
doaj +3 more sources
Proton Pump Inhibitors in Kidney Disease [PDF]
Clinical Journal of the American Society of Nephrology, 2018 Proton pump inhibitors (PPIs) are one of the most frequently used classes of medications in the world, and they are particularly common among patients receiving hemodialysis. In 2015, nearly one half of all Medicare-enrolled patients on hemodialysis received a prescription for an acid suppressant ([
Lazarus, Benjamin, Grams, Morgan E.
openaire +4 more sources
Hypocalcemia After Thyroidectomy in Patients Taking Proton Pump Inhibitors
Laryngoscope Investigative OtolaryngologyObjective Calcium homeostasis is regulated by the effects of parathyroid hormone (PTH) and vitamin D on the bones, GI tract, and kidneys. Post‐thyroidectomy hypoparathyroidism and resultant hypocalcemia are common complications associated with prolonged ...
Maxwell Rossip +3 more
doaj +1 more source